Atlas Trials

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Clinical trial NCT00335504 · COMPLETED

Trial details

NCT number
NCT00335504
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon CancerPrecancerous ConditionRectal Cancer
Start date
2006-03-01
Primary completion
2009-04-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.